![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page1055.jpg)
Conclusion (5)
Sequential / concurrent CTRT can be safely administered if
•
WHO performance status 0-1
•
no major comorbidity
•
age ≤ 70-75 years
1A
Only cisplatin, carboplatin, etoposide, paclitaxel, docetaxel,
and vinorelbine can be safely combined with concurrent
radiotherapy
1A
Dose to central bronchi ≤ 80 Gy if concurrent CT-RT
1B
De Ruysscher EORTC JCO 2010